|
Name |
1-Heptadecanol
|
Molecular Formula | C17H36O | |
IUPAC Name* |
heptadecan-1-ol
|
|
SMILES |
CCCCCCCCCCCCCCCCCO
|
|
InChI |
InChI=1S/C17H36O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18/h18H,2-17H2,1H3
|
|
InChIKey |
GOQYKNQRPGWPLP-UHFFFAOYSA-N
|
|
Synonyms |
1-Heptadecanol; Heptadecan-1-ol; 1454-85-9; Heptadecanol; HEPTADECYL ALCOHOL; n-Heptadecanol; 1-Hydroxyheptadecane; N3IL85TMCX; CHEBI:77470; NSC-3921; NSC 3921; EINECS 215-932-5; UNII-N3IL85TMCX; AI3-01234; n-Heptadecanol-1; n-heptadecyl alcohol; MFCD00002822; MARGARIC ALCOHOL; 1-Heptadecanol, 98%; DSSTox_CID_8323; HEPTADECANOL, 1-; DSSTox_GSID_28323; SCHEMBL29893; CHEMBL278989; DTXSID3051460; AMY5933; NSC3921; Tox21_303960; ZINC43649353; AKOS015899030; CS-W004296; HY-W004296; NCGC00356985-01; 1-Heptadecanol, purum, >=97.0% (GC); CAS-67762-27-0; FT-0607873; H0018; O11822; A884612; J-008119; Q20054528; 60EE1D22-0C43-4AEE-B6F6-FBD44178F59F
|
|
CAS | 1454-85-9 | |
PubChem CID | 15076 | |
ChEMBL ID | CHEMBL278989 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 256.5 | ALogp: | 7.8 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 20.2 | Aromatic Rings: | 0 |
Heavy Atoms: | 18 | QED Weighted: | 0.359 |
Caco-2 Permeability: | -4.777 | MDCK Permeability: | 0.00001410 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.139 |
30% Bioavailability (F30%): | 0.994 |
Blood-Brain-Barrier Penetration (BBB): | 0.084 | Plasma Protein Binding (PPB): | 97.45% |
Volume Distribution (VD): | 2.866 | Fu: | 1.58% |
CYP1A2-inhibitor: | 0.308 | CYP1A2-substrate: | 0.188 |
CYP2C19-inhibitor: | 0.334 | CYP2C19-substrate: | 0.054 |
CYP2C9-inhibitor: | 0.112 | CYP2C9-substrate: | 0.943 |
CYP2D6-inhibitor: | 0.031 | CYP2D6-substrate: | 0.044 |
CYP3A4-inhibitor: | 0.169 | CYP3A4-substrate: | 0.038 |
Clearance (CL): | 5.542 | Half-life (T1/2): | 0.122 |
hERG Blockers: | 0.252 | Human Hepatotoxicity (H-HT): | 0.011 |
Drug-inuced Liver Injury (DILI): | 0.061 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.019 | Maximum Recommended Daily Dose: | 0.013 |
Skin Sensitization: | 0.956 | Carcinogencity: | 0.04 |
Eye Corrosion: | 0.993 | Eye Irritation: | 0.929 |
Respiratory Toxicity: | 0.505 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000284 | 0.945 | D00AOJ | 0.776 | ||||
ENC000082 | 0.942 | D07ILQ | 0.697 | ||||
ENC000745 | 0.897 | D0Z5SM | 0.559 | ||||
ENC000426 | 0.885 | D00FGR | 0.549 | ||||
ENC000431 | 0.852 | D0O1PH | 0.513 | ||||
ENC000400 | 0.825 | D05ATI | 0.478 | ||||
ENC000761 | 0.813 | D00STJ | 0.419 | ||||
ENC000110 | 0.787 | D0P1RL | 0.367 | ||||
ENC000521 | 0.783 | D0T9TJ | 0.351 | ||||
ENC000527 | 0.783 | D0MM8N | 0.341 |